Source:http://linkedlifedata.com/resource/pubmed/id/11122295
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2001-2-13
|
| pubmed:abstractText |
It has been shown that sera from patients with autoimmune inner ear disease contain antibodies to several inner ear antigens. We report here the characterization of the 42-43 kDa protein against which a significant number of patients' sera react strongly. After separation of inner ear proteins from guinea-pig cochleas by SDS-PAGE, the band corresponding to the 42-43 kDa protein was digested with trypsin and the peptide fragments were separated by high-performance liquid chromatography. Two fractions were then subjected to amino acid sequencing by the classical automated Edman degradation. The sequence of a stretch of 15 amino acids of the first fragment was identical to that of amino acids 148-162 of beta-actin. The sequence of the 10 amino acids of the second fragment was also identical to beta-actin. On Western blots, monoclonal antibody directed against beta-actin reacted with the inner ear 42-43 kDa proteins. The serum samples from the patients and the monoclonal antibody reacted with the non-muscle actin used as antigen in Western blotting. Immunoblot analysis of inner ear proteins after two-dimensional gel electrophoresis showed a spot, corresponding to the region of the 43 kDa as compared to the protein standards. On the basis of these data it is concluded that the target 42-43 kDa protein for antibodies in sera of patients with autoimmune inner ear disease is beta-actin, a molecule, which has important and numerous functions inside cells. This is the first report to identify the cytoskeletal protein beta-actin as a candidate autoantigen in autoimmune inner ear disease.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0307-7772
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
25
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
535-41
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:11122295-Actins,
pubmed-meshheading:11122295-Animals,
pubmed-meshheading:11122295-Autoantibodies,
pubmed-meshheading:11122295-Autoantigens,
pubmed-meshheading:11122295-Blotting, Western,
pubmed-meshheading:11122295-Carrier Proteins,
pubmed-meshheading:11122295-Ear, Inner,
pubmed-meshheading:11122295-Ear Diseases,
pubmed-meshheading:11122295-Female,
pubmed-meshheading:11122295-Fluorescent Antibody Technique, Indirect,
pubmed-meshheading:11122295-Guinea Pigs,
pubmed-meshheading:11122295-Male
|
| pubmed:year |
2000
|
| pubmed:articleTitle |
Identification of beta-actin as a candidate autoantigen in autoimmune inner ear disease.
|
| pubmed:affiliation |
Laboratory of Autoimmunity and Department of Otorhinolaryngology, University of Louvain Medical School, 1200 Brussels, Belgium. Rachid.Boulassel@mblg.ucl.ac.be
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|